http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0995752-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24a14cc1ad3881d897b18482a3289502 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-22 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-22 |
| filingDate | 1998-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fddd3c2ba674957617618d457ea9fdb5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_605725b6baa4b9081661d0412b57e6c6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_673487f902e26138715f9ed6a298db82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d8351174b3a3b314fa6970514c97f00 |
| publicationDate | 2000-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0995752-A1 |
| titleOfInvention | Triazolo-1,4-diazepine compounds and medicinal composition containing the same |
| abstract | A triazolo-1,4-diazepine compound having the formulan(I):n nwherein A represents CO, CO-B, or B, B represents a C 1 tonC 6 alkylene group or a C 2 to C 6 alkylene group having annoxygen atom interposed in the middle thereof, Xnrepresents N-O or CH, n represents an integer of 2 to 6,nR represents a hydroxyl group, a C 1 to C 6 lower alkyloxyngroup or a C 1 to C 6 lower alkylamino group, provided thatnthese groups may be substituted with an N,N-dimethylaminongroup, an N,N-diethylamino group, a phenyl group, or anheterocyclic group, and R 1 represents a hydrogen atom orna C 1 to C 3 lower alkyl group having both a PAFnantogonistic action and a thromboxane synthesisninhibiting action, and a pharmaceutical compositionncontaining the same as an active ingredient. |
| priorityDate | 1997-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 166.